Related references
Note: Only part of the references are listed.Regenerative potential of prostate luminal cells revealed by single-cell analysis
Wouter R. Karthaus et al.
SCIENCE (2020)
Evaluation of Intense Androgen Deprivation Before Prostatectomy: A Randomized Phase II Trial of Enzalutamide and Leuprolide With or Without Abiraterone
Rana R. McKay et al.
JOURNAL OF CLINICAL ONCOLOGY (2019)
Clinical and Biological Characterisation of Localised High-risk Prostate Cancer: Results of a Randomised Preoperative Study of a Luteinising Hormone-releasing Hormone Agonist with or Without Abiraterone Acetate plus Prednisone
Eleni Efstathiou et al.
EUROPEAN UROLOGY (2019)
Molecular regulation of Snai2 in development and disease
Wenhui Zhou et al.
JOURNAL OF CELL SCIENCE (2019)
Neoadjuvant-Intensive Androgen Deprivation Therapy Selects for Prostate Tumor Foci with Diverse Subclonal Oncogenic Alterations
Adam G. Sowalsky et al.
CANCER RESEARCH (2018)
Identification of the tumour transition states occurring during EMT
Ievgenia Pastushenko et al.
NATURE (2018)
Androgen synthesis in prostate cancer: do all roads lead to Rome?
Ryan Stuchbery et al.
NATURE REVIEWS UROLOGY (2017)
Intratumoral and Intertumoral Genomic Heterogeneity of Multifocal Localized Prostate Cancer Impacts Molecular Classifications and Genomic Prognosticators
Lei Wei et al.
EUROPEAN UROLOGY (2017)
Rare cell variability and drug- induced reprogramming as a mode of cancer drug resistance
Sydney M. Shaffer et al.
NATURE (2017)
Recurrent Tumor Cell-Intrinsic and -Extrinsic Alterations during MAPKi-Induced Melanoma Regression and Early Adaptation
Chunying Song et al.
CANCER DISCOVERY (2017)
Repression of Stress-Induced LINE-1 Expression Protects Cancer Cell Subpopulations from Lethal Drug Exposure
Gulfem Dilek Guler et al.
CANCER CELL (2017)
Clonal Heterogeneity and Tumor Evolution: Past, Present, and the Future
Nicholas McGranahan et al.
CELL (2017)
Aberrant JMJD3 Expression Upregulates Slug to Promote Migration, Invasion, and Stem Cell-Like Behaviors in Hepatocellular Carcinoma
Bo Tang et al.
CANCER RESEARCH (2016)
Slug inhibition increases radiosensitivity of oral squamous cell carcinoma cells by upregulating PUMA
Fangfang Jiang et al.
INTERNATIONAL JOURNAL OF ONCOLOGY (2016)
Androgen receptor inhibits epithelial-mesenchymal transition, migration, and invasion of PC-3 prostate cancer cells
Chieh Huo et al.
CANCER LETTERS (2015)
The Molecular Taxonomy of Primary Prostate Cancer
Adam Abeshouse et al.
CELL (2015)
SNAI2/Slug gene is silenced in prostate cancer and regulates neuroendocrine differentiation, metastasis-suppressor and pluripotency gene expression
Silvia Esposito et al.
ONCOTARGET (2015)
A stress-induced early innate response causes multidrug tolerance in melanoma
D. Ravindran Menon et al.
ONCOGENE (2015)
Emerging mechanisms of resistance to androgen receptor inhibitors in prostate cancer
Philip A. Watson et al.
NATURE REVIEWS CANCER (2015)
Canonical Androstenedione Reduction Is the Predominant Source of Signaling Androgens in Hormone-Refractory Prostate Cancer
Matthew Fankhauser et al.
CLINICAL CANCER RESEARCH (2014)
Next-generation Sequencing of Advanced Prostate Cancer Treated with Androgen-deprivation Therapy
Prabhakar Rajan et al.
EUROPEAN UROLOGY (2014)
Targeted Androgen Pathway Suppression in Localized Prostate Cancer: A Pilot Study
Elahe A. Mostaghel et al.
JOURNAL OF CLINICAL ONCOLOGY (2014)
Intense Androgen-Deprivation Therapy With Abiraterone Acetate Plus Leuprolide Acetate in Patients With Localized High-Risk Prostate Cancer: Results of a Randomized Phase II Neoadjuvant Study
Mary-Ellen Taplin et al.
JOURNAL OF CLINICAL ONCOLOGY (2014)
PyClone: statistical inference of clonal population structure in cancer
Andrew Roth et al.
NATURE METHODS (2014)
AR-V7 and Resistance to Enzalutamide and Abiraterone in Prostate Cancer
Emmanuel S. Antonarakis et al.
NEW ENGLAND JOURNAL OF MEDICINE (2014)
Heterogeneity in the inter-tumor transcriptome of high risk prostate cancer
Alexander W. Wyatt et al.
GENOME BIOLOGY (2014)
Glucocorticoid Receptor Confers Resistance to Antiandrogens by Bypassing Androgen Receptor Blockade
Vivek K. Arora et al.
CELL (2013)
A Gain-of-Function Mutation in DHT Synthesis in Castration-Resistant Prostate Cancer
Kai-Hsiung Chang et al.
CELL (2013)
Cancer drug resistance: an evolving paradigm
Caitriona Holohan et al.
NATURE REVIEWS CANCER (2013)
EMT transcription factors snail and slug directly contribute to cisplatin resistance in ovarian cancer
Alexandria M. Haslehurst et al.
BMC CANCER (2012)
Androgen Deprivation Causes Epithelial-Mesenchymal Transition in the Prostate: Implications for Androgen-Deprivation Therapy
Yuting Sun et al.
CANCER RESEARCH (2012)
Mutational Processes Molding the Genomes of 21 Breast Cancers
Serena Nik-Zainal et al.
CELL (2012)
Critical and Reciprocal Regulation of KLF4 and SLUG in Transforming Growth Factor β-Initiated Prostate Cancer Epithelial-Mesenchymal Transition
Yen-Nien Liu et al.
MOLECULAR AND CELLULAR BIOLOGY (2012)
The mutational landscape of lethal castration-resistant prostate cancer
Catherine S. Grasso et al.
NATURE (2012)
Dynamic epigenetic regulation of the microRNA-200 family mediates epithelial and mesenchymal transitions in human tumorigenesis
V. Davalos et al.
ONCOGENE (2012)
Microscopic assessment of fresh prostate tumour specimens yields significantly increased rates of correctly annotated samples for downstream analysis
Michael Kerger et al.
PATHOLOGY (2012)
Slug Confers Resistance to the Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitor
Tzu-Hua Chang et al.
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE (2011)
Dihydrotestosterone synthesis bypasses testosterone to drive castration-resistant prostate cancer
Kai-Hsiung Chang et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2011)
TGF-β1-Induced EMT of Non-Transformed Prostate Hyperplasia Cells Is Characterized by Early Induction of SNAI2/Slug
Eva Slabakova et al.
PROSTATE (2011)
SNAI2/Slug promotes growth and invasion in human gliomas
Hong Wei Yang et al.
BMC CANCER (2010)
SLUG/SNAI2 and Tumor Necrosis Factor Generate Breast Cells With CD44+/CD24-Phenotype
Poornima Bhat-Nakshatri et al.
BMC CANCER (2010)
A Chromatin-Mediated Reversible Drug-Tolerant State in Cancer Cell Subpopulations
Sreenath V. Sharma et al.
CELL (2010)
Role of androgens and the androgen receptor in epithelial-mesenchymal transition and invasion of prostate cancer cells
Meng-Lei Zhu et al.
FASEB JOURNAL (2010)
Tumor Volume in Radical Prostatectomy Specimens Assessed by Digital Image Analysis Software Correlates With Other Prognostic Factors
Justin C. Sherwin et al.
JOURNAL OF UROLOGY (2010)
Slug/SNAI2 regulates cell proliferation and invasiveness of metastatic prostate cancer cell lines
Modjtaba Emadi Baygi et al.
TUMOR BIOLOGY (2010)
Ligand-Independent Androgen Receptor Variants Derived from Splicing of Cryptic Exons Signify Hormone-Refractory Prostate Cancer
Rong Hu et al.
CANCER RESEARCH (2009)
Snail and Slug Mediate Radioresistance and Chemoresistance by Antagonizing p53-Mediated Apoptosis and Acquiring a Stem-Like Phenotype in Ovarian Cancer Cells
Nawneet K. Kurrey et al.
STEM CELLS (2009)
Maintenance of intratumoral androgens in metastatic prostate cancer: A mechanism for castration-resistant tumor growth
R. Bruce Montgomery et al.
CANCER RESEARCH (2008)
Slug (SNAI2) down-regulation by RNA interference facilitates apoptosis and inhibits invasive growth in neuroblastoma preclinical models
Roberta Vitali et al.
CLINICAL CANCER RESEARCH (2008)
Slug expression is an independent prognostic parameter for poor survival in colorectal carcinoma patients
M. Shioiri et al.
BRITISH JOURNAL OF CANCER (2006)
Transcription repressor Slug promotes carcinoma invasion and predicts outcome of patients with lung adenocarcinoma
JY Shih et al.
CLINICAL CANCER RESEARCH (2005)
Slug antagonizes p53-mediated apoptosis of hematopoietic progenitors by repressing puma
WS Wu et al.
CELL (2005)
Molecular determinants of resistance to antiandrogen therapy
CD Chen et al.
NATURE MEDICINE (2004)
Share Paper
